Skip to Content

Rule

New Animal Drugs; Change of Sponsor

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 43 approved new animal drug applications (NADAs) and 3 approved abbreviated new animal drug applications (ANADAs) from Boehringer Ingelheim Vetmedica, Inc. to Strategic Veterinary Pharmaceuticals, Inc.

DATES:

This rule is effective April 9, 2013.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, email: steven.vaughn@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Boehringer Ingelheim Vetmedica, Inc., 2621 North Belt Highway, St. Joseph, MO 64506-2002 has informed FDA that it has transferred ownership of, and all rights and interest in, the following 43 approved NADAs and 3 approved ANADAs to Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503:

Table 1.—Applications Transferred

Application No.Trade name
11-531DIZAN (dithiazanine iodide) Tablets.
11-674DIZAN (dithiazanine iodide) Powder.
12-469DIZAN Suspension With Piperazine.
31-512ATGARD (dichlovos) Swine Wormer Type A Medicated Article.
33-803TASK (dichlovos) Dog Anthelmintic.
35-918EQUIGARD (dichlovos).
38-200MEDAMYCIN (oxytetracycline hydrochloride) Soluble Antibiotic.
39-483BIO-TAL (thiamylal sodium) Injectable Solution.
40-848ATGARD C (dichlovos) Swine Wormer Type A Medicated Article.
43-606ATGARD V (dichlovos) Swine Wormer Type A Medicated Article.
45-143OXYJECT (oxytetracycline hydrochloride) Injectable Solution.
47-278OXY-TET 50 (oxytetracycline hydrochloride) Injectable Solution.
47-712BIZOLIN-100 (phenylbutazone) Tablets.
48-010ANAPLEX (dichlorophene and toluene) Capsules.
48-237EQUIGEL (dichlovos) Oral Gel.
48-271TASK (dichlovos) Tablets.
49-032ATGARD C (dichlovos) 9.6% Type A Medicated Article.
55-097DRY-MAST (penicillin G procaine/dihydrostreptomycin sulfate) Intramammary Infusion.
65-178FERMYCIN (chlortetracycline hydrochloride or chlortetracycline bisulfate) Soluble Powder.
65-461ANACETIN (chloramphenicol) Tablets.
65-481Chlortetracycline Pneumonia/Calf Scour Boluses.
65-486Chlortetracycline Bisulfate Soluble Powder.
65-491MEDICHOL (chloramphenicol) Tablets.
65-496Tetracycline Soluble Powder.
92-837NEMACIDE (diethylcarbamazine citrate) Oral Syrup.
93-516BIZOLIN (phenylbutazone) Injection 20%.
97-452OXYJECT 100 (oxytetracycline hydrochloride) Injectable Solution.
98-569MEDACIDE-SDM (sulfadimethoxine) Injection 10%.
99-618BIZOLIN (phenylbutazone) 1-G Tablets.
108-963MEDAMYCIN (oxytetracycline hydrochloride) Injectable Solution.
Start Printed Page 21059
109-305Oxytocin Injection.
117-689NEUROSYN (primidone) Tablets.
125-797Nitrofurazone Dressing.
126-236Nitrofurazone Soluble Powder.
126-676D & T (dichlorophene and toluene) Worm Capsules.
127-627NEMACIDE-C (diethylcarbamazine citrate) Tablets.
128-069NEMACIDE (diethylcarbamazine citrate) Chewable Tablets.
132-028ANESTATAL (thiamylal sodium) Powder for Injection.
135-771Methylprednisolene Tablets.
136-212Methylprednisolone Acetate Injectable Suspension.
137-310Gentamicin Sulfate Injectable Solution.
138-869Triamcinolone Acetonide Injectable Suspension.
140-442Xylazine HCl Injection.
200-023Gentamicin Sulfate Intrauterine Solution.
200-029Ketamine Hydrochloride Injection.
200-165SDM (sulfadimethoxine) 12.5% Oral Solution.

Accordingly, the Agency is amending the regulations in 21 CFR parts 510, 520, 522, 524, 526, 529, and 558 to reflect the transfer of ownership.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

21 CFR Part 510

  • Administrative practice and procedure
  • Animal drugs
  • Labeling
  • Reporting and recordkeeping requirements

21 CFR Parts 520, 522, 524, 526, and 529

  • Animal drugs

21 CFR Part 558

  • Animal drugs
  • Animal feeds
End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, 526, 529, and 558 are amended as follows:

Start Part

PART 510—NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for 21 CFR part 510 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority Start Amendment Part

2. In the table in paragraph (c)(1) of § 510.600, alphabetically add an entry for “Strategic Veterinary Pharmaceuticals, Inc.”; and in the table in paragraph (c)(2), numerically add an entry for “054628” to read as follows:

End Amendment Part
Names, addresses, and drug labeler codes of sponsors of approved applications.
* * * * *

(c) * * *

(1) * * *

Firm name and addressDrug labeler code
*    *    *    *    *
Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503054628
*    *    *    *    *

(2) * * *

Drug labeler codeFirm name and address
*    *    *    *    *
054628Strategic Veterinary Pharmaceuticals, Inc., 100 NW. Airport Rd., St. Joseph, MO 64503
*    *    *    *    *
Start Part

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

3. The authority citation for 21 CFR part 520 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

4. In paragraph (b)(1)(i) of § 520.390a, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

5. In paragraph (b)(3) of § 520.441, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

6. In paragraph (b) of § 520.443, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

7. In paragraph (b)(2), remove “000010 and 000061” and in its place add “Nos. 000061 and 054628”.

End Amendment Part
[Amended]
Start Amendment Part

8. In paragraph (c) of § 520.600, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

9. In paragraph (a)(6) of § 520.622a, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

10. In paragraph (c)(2) of § 520.622b, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

11. In paragraph (b)(6) of § 520.622c, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

12. In § 520.763a, remove and reserve paragraph (a); in paragraph (c), remove “000010” and in its place add “054628”; and remove paragraph (e).

End Amendment Part
[Amended]
Start Amendment Part

13. In § 520.763b, remove and reserve paragraph (a); and in paragraph (c), remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

14. In paragraph (b) of § 520.763c, remove “000010” and in its place add “054628”; and remove and reserve paragraph (c).

End Amendment Part
Start Printed Page 21060
[Amended]
Start Amendment Part

15. In paragraph (b) of § 520.1408, remove “000010” and in its place add “054628”; and remove and reserve paragraph (c).

End Amendment Part
[Amended]
Start Amendment Part

16. In § 520.1660d:

End Amendment Part Start Amendment Part

a. In paragraph (b)(3), remove “000010” and in its place add “054628”.

End Amendment Part Start Amendment Part

b. In paragraph (d)(1)(ii)(A)( 3), remove “000010” and in its place add “054628”.

End Amendment Part Start Amendment Part

c. In paragraph (d)(1)(ii)(B)( 3), remove “000010” and in its place add “054628”.

End Amendment Part Start Amendment Part

d. In paragraph (d)(1)(ii)(C)( 3), remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

17. In paragraph (b)(2) of § 520.1720a, remove “000010 and 000859” and in its place add “000859 and 054628”.

End Amendment Part
[Amended]
Start Amendment Part

18. In paragraph (b) of § 520.1900, remove “000010” and in its place add “054628”; and in paragraphs (c)(1), (c)(2), and (c)(3), remove the footnote.

End Amendment Part
[Amended]
Start Amendment Part

19. In paragraph (a)(1) of § 520.2220a, remove “000010, 000069, 000859, 054925, and 057561” and in its place add “000069, 000859, 054628, 054925, and 057561”.

End Amendment Part
[Amended]
Start Amendment Part

20. In paragraph (b)(2) of § 520.2345d, remove “000010” and in its place add “054628”.

End Amendment Part Start Part

PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

21. The authority citation for 21 CFR part 522 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

22. In paragraph (b)(3) of § 522.1044, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

23. In paragraph (b) of § 522.1222a, remove “000010, 000859, 061690, 026637, and 063286” and in its place add “000859, 026637, 054628, 061690, and 063286”.

End Amendment Part
[Amended]
Start Amendment Part

24. In paragraph (b) of § 522.1410, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

25. In paragraphs (a)(2), (b)(2), (g)(2), and (h)(2) of § 522.1662a, remove “000010” and in its place add “054628”.

End Amendment Part Start Amendment Part

26. In § 522.1680, revise the section heading to read as set forth below; and in paragraph (b), remove “000010, 000856, 000859, and 061623” and in its place add “000856, 000859, 054628, and 061623”.

End Amendment Part
Oxytocin.
* * * * *
Start Amendment Part

27. In § 522.1720, revise the section heading to read as set forth below; and in paragraph (b)(2), remove “000010” and in its place add “054628”.

End Amendment Part
Phenylbutazone.
* * * * *
Start Amendment Part

28. In § 522.2220, revise the section heading as set forth below; and in paragraph (c)(2), remove “000010” and in its place add “054628”.

End Amendment Part
Sulfadimethoxine.
* * * * *
Start Amendment Part

29. In § 522.2424, revise the section heading as set forth below; and in paragraph (b), remove “000010 and 000856” and in its place add “000856 and 054628”; and remove paragraph (c)(4).

End Amendment Part
Sodium thiamylal.
* * * * *
[Amended]
Start Amendment Part

30. In paragraph (b) of § 522.2483, remove “000010” and in its place add “054628”.

End Amendment Part
[Amended]
Start Amendment Part

31. In paragraph (b)(1) of § 522.2662, remove “000010” and in its place add “054628”.

End Amendment Part Start Part

PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

32. The authority citation for 21 CFR part 524 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

33. In paragraph (b)(1) of § 524.1580b, remove “000010, 000069, 050749, 054925, 058005, and 061623” and in its place add “000069, 050749, 054628, 054925, 058005, and 061623”.

End Amendment Part
[Amended]
Start Amendment Part

34. In paragraph (b) of § 524.1580c, remove “000010 and 000069” and in its place add “000069 and 054628”.

End Amendment Part Start Part

PART 526—INTRAMAMMARY DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

35. The authority citation for 21 CFR part 526 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

36. In paragraph (b) of § 526.1696b, remove “000010” and in its place add “054628”.

End Amendment Part Start Part

PART 529—CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

37. The authority citation for 21 CFR part 529 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

38. In paragraph (b) of § 529.1044a, remove “000010, 000061, 000856, 000859 057561, 058005, and 061623” and in its place add “000061, 000856, 000859, 054628, 057561, 058005, and 061623”.

End Amendment Part Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

End Part Start Amendment Part

39. The authority citation for 21 CFR part 558 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority
[Amended]
Start Amendment Part

40. In paragraph (a) of § 558.205, remove “000010” and in its place add “054628”.

End Amendment Part Start Signature

Dated: March 26, 2013.

Steven D. Vaughn,

Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 2013-07542 Filed 4-8-13; 8:45 am]

BILLING CODE 4160-01-P